XERS financials
Xeris Biopharma (XERS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
XERS income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $291.85M | $238.43M | $24.90M | $554.00K | 0.00 |
| 2024 | $203.07M | $166.24M | -$33.65M | -$54.84M | -0.37 |
| 2023 | $163.91M | $135.27M | -$44.01M | -$62.26M | -0.45 |
| 2022 | $110.25M | $87.61M | -$81.94M | -$94.66M | -0.70 |
| 2021 | $49.59M | $36.27M | -$115.16M | -$122.72M | -1.55 |
| 2020 | $20.43M | $11.11M | -$83.55M | -$91.14M | -2.14 |
- XERS revenue was $291.85M in fiscal 2025, net income $554.00K.
Updated 2026-11-02 23:14 UTC